DERMAPHARM HOLDING SE (DMP.DE) Fundamental Analysis & Valuation

FRA:DMP • DE000A2GS5D8

Current stock price

46.35 EUR
+0.3 (+0.65%)
Last:

This DMP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DMP.DE Profitability Analysis

1.1 Basic Checks

  • In the past year DMP was profitable.
  • In the past year DMP had a positive cash flow from operations.
  • In the past 5 years DMP has always been profitable.
  • DMP had a positive operating cash flow in each of the past 5 years.
DMP.DE Yearly Net Income VS EBIT VS OCF VS FCFDMP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.06%, DMP is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • The Return On Equity of DMP (19.07%) is better than 73.47% of its industry peers.
  • DMP's Return On Invested Capital of 8.17% is in line compared to the rest of the industry. DMP outperforms 57.14% of its industry peers.
  • DMP had an Average Return On Invested Capital over the past 3 years of 8.49%. This is significantly below the industry average of 14.21%.
Industry RankSector Rank
ROA 6.06%
ROE 19.07%
ROIC 8.17%
ROA(3y)4.8%
ROA(5y)7.76%
ROE(3y)16.49%
ROE(5y)23.37%
ROIC(3y)8.49%
ROIC(5y)11.55%
DMP.DE Yearly ROA, ROE, ROICDMP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • DMP's Profit Margin of 11.37% is in line compared to the rest of the industry. DMP outperforms 53.06% of its industry peers.
  • DMP's Profit Margin has been stable in the last couple of years.
  • With a Operating Margin value of 18.94%, DMP perfoms like the industry average, outperforming 53.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DMP has grown nicely.
  • With a Gross Margin value of 67.21%, DMP perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • DMP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.94%
PM (TTM) 11.37%
GM 67.21%
OM growth 3Y-8.84%
OM growth 5Y3.09%
PM growth 3Y-4.62%
PM growth 5Y1.01%
GM growth 3Y1.39%
GM growth 5Y2.85%
DMP.DE Yearly Profit, Operating, Gross MarginsDMP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DMP.DE Health Analysis

2.1 Basic Checks

  • DMP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, DMP has about the same amount of shares outstanding.
  • DMP has about the same amout of shares outstanding than it did 5 years ago.
  • DMP has a worse debt/assets ratio than last year.
DMP.DE Yearly Shares OutstandingDMP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
DMP.DE Yearly Total Debt VS Total AssetsDMP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • DMP has an Altman-Z score of 2.41. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of DMP (2.41) is comparable to the rest of the industry.
  • The Debt to FCF ratio of DMP is 5.63, which is a neutral value as it means it would take DMP, 5.63 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.63, DMP is in line with its industry, outperforming 46.94% of the companies in the same industry.
  • A Debt/Equity ratio of 1.33 is on the high side and indicates that DMP has dependencies on debt financing.
  • The Debt to Equity ratio of DMP (1.33) is worse than 75.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF 5.63
Altman-Z 2.41
ROIC/WACC1.18
WACC6.92%
DMP.DE Yearly LT Debt VS Equity VS FCFDMP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.05 indicates that DMP has no problem at all paying its short term obligations.
  • The Current ratio of DMP (2.05) is better than 75.51% of its industry peers.
  • A Quick Ratio of 1.09 indicates that DMP should not have too much problems paying its short term obligations.
  • The Quick ratio of DMP (1.09) is better than 63.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.09
DMP.DE Yearly Current Assets VS Current LiabilitesDMP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DMP.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.36% over the past year.
  • DMP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.06% yearly.
  • Looking at the last year, DMP shows a decrease in Revenue. The Revenue has decreased by -1.34% in the last year.
  • Measured over the past years, DMP shows a small growth in Revenue. The Revenue has been growing by 7.97% on average per year.
EPS 1Y (TTM)16.36%
EPS 3Y-0.45%
EPS 5Y9.06%
EPS Q2Q%80.37%
Revenue 1Y (TTM)-1.34%
Revenue growth 3Y4.37%
Revenue growth 5Y7.97%
Sales Q2Q%1.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.52% on average over the next years. This is quite good.
  • Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 4.07% on average per year.
EPS Next Y8.33%
EPS Next 2Y8.91%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue Next Year3.45%
Revenue Next 2Y3.6%
Revenue Next 3Y3.47%
Revenue Next 5Y4.07%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DMP.DE Yearly Revenue VS EstimatesDMP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
DMP.DE Yearly EPS VS EstimatesDMP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. DMP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.84 indicates a rather expensive valuation of DMP.
  • DMP's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of DMP to the average of the S&P500 Index (26.64), we can say DMP is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 18.78 indicates a rather expensive valuation of DMP.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. DMP is around the same levels.
Industry RankSector Rank
PE 18.84
Fwd PE 18.78
DMP.DE Price Earnings VS Forward Price EarningsDMP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 69.39% of the companies in the same industry are more expensive than DMP, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, DMP is valued cheaply inside the industry as 83.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.34
EV/EBITDA 10.67
DMP.DE Per share dataDMP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • DMP's earnings are expected to grow with 13.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.26
PEG (5Y)2.08
EPS Next 2Y8.91%
EPS Next 3Y13.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DMP.DE Dividend Analysis

5.1 Amount

  • DMP has a Yearly Dividend Yield of 1.90%.
  • Compared to an average industry Dividend Yield of 1.91, DMP has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, DMP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.9%

5.2 History

  • The dividend of DMP has a limited annual growth rate of 2.38%.
Dividend Growth(5Y)2.38%
Div Incr Years0
Div Non Decr Years0
DMP.DE Yearly Dividends per shareDMP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • DMP pays out 36.59% of its income as dividend. This is a sustainable payout ratio.
  • DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP36.59%
EPS Next 2Y8.91%
EPS Next 3Y13.52%
DMP.DE Yearly Income VS Free CF VS DividendDMP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DMP.DE Dividend Payout.DMP.DE Dividend Payout, showing the Payout Ratio.DMP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DMP.DE Fundamentals: All Metrics, Ratios and Statistics

DERMAPHARM HOLDING SE

FRA:DMP (4/30/2026, 7:00:00 PM)

46.35

+0.3 (+0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength54.73
Industry Growth58.67
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners11.14%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.50B
Revenue(TTM)1.16B
Net Income(TTM)132.41M
Analysts78.18
Price Target41.82 (-9.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.9%
Yearly Dividend0.9
Dividend Growth(5Y)2.38%
DP36.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.3%
PT rev (3m)-2.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.93%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 18.84
Fwd PE 18.78
P/S 2.14
P/FCF 13.34
P/OCF 10.89
P/B 3.59
P/tB N/A
EV/EBITDA 10.67
EPS(TTM)2.46
EY5.31%
EPS(NY)2.47
Fwd EY5.33%
FCF(TTM)3.47
FCFY7.5%
OCF(TTM)4.26
OCFY9.18%
SpS21.64
BVpS12.9
TBVpS-6.93
PEG (NY)2.26
PEG (5Y)2.08
Graham Number26.718 (-42.36%)
Profitability
Industry RankSector Rank
ROA 6.06%
ROE 19.07%
ROCE 11.97%
ROIC 8.17%
ROICexc 9.21%
ROICexgc 26.47%
OM 18.94%
PM (TTM) 11.37%
GM 67.21%
FCFM 16.06%
ROA(3y)4.8%
ROA(5y)7.76%
ROE(3y)16.49%
ROE(5y)23.37%
ROIC(3y)8.49%
ROIC(5y)11.55%
ROICexc(3y)9.32%
ROICexc(5y)13.08%
ROICexgc(3y)28.01%
ROICexgc(5y)33.07%
ROCE(3y)12.54%
ROCE(5y)16.99%
ROICexgc growth 3Y-14%
ROICexgc growth 5Y2.3%
ROICexc growth 3Y-19.19%
ROICexc growth 5Y-0.36%
OM growth 3Y-8.84%
OM growth 5Y3.09%
PM growth 3Y-4.62%
PM growth 5Y1.01%
GM growth 3Y1.39%
GM growth 5Y2.85%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF 5.63
Debt/EBITDA 2.95
Cap/Depr 45.77%
Cap/Sales 3.62%
Interest Coverage 4.26
Cash Conversion 73.29%
Profit Quality 141.26%
Current Ratio 2.05
Quick Ratio 1.09
Altman-Z 2.41
F-Score7
WACC6.92%
ROIC/WACC1.18
Cap/Depr(3y)43.55%
Cap/Depr(5y)61.4%
Cap/Sales(3y)3.5%
Cap/Sales(5y)4.16%
Profit Quality(3y)189.52%
Profit Quality(5y)168.94%
High Growth Momentum
Growth
EPS 1Y (TTM)16.36%
EPS 3Y-0.45%
EPS 5Y9.06%
EPS Q2Q%80.37%
EPS Next Y8.33%
EPS Next 2Y8.91%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.34%
Revenue growth 3Y4.37%
Revenue growth 5Y7.97%
Sales Q2Q%1.67%
Revenue Next Year3.45%
Revenue Next 2Y3.6%
Revenue Next 3Y3.47%
Revenue Next 5Y4.07%
EBIT growth 1Y1.72%
EBIT growth 3Y-4.86%
EBIT growth 5Y11.31%
EBIT Next Year47.82%
EBIT Next 3Y17.6%
EBIT Next 5Y8.79%
FCF growth 1Y14.63%
FCF growth 3Y-9.16%
FCF growth 5Y15.47%
OCF growth 1Y13.78%
OCF growth 3Y-7.39%
OCF growth 5Y11.68%

DERMAPHARM HOLDING SE / DMP.DE Fundamental Analysis FAQ

What is the fundamental rating for DMP stock?

ChartMill assigns a fundamental rating of 4 / 10 to DMP.DE.


Can you provide the valuation status for DERMAPHARM HOLDING SE?

ChartMill assigns a valuation rating of 3 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Overvalued.


Can you provide the profitability details for DERMAPHARM HOLDING SE?

DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for DMP stock?

The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 18.84 and the Price/Book (PB) ratio is 3.59.


How sustainable is the dividend of DERMAPHARM HOLDING SE (DMP.DE) stock?

The dividend rating of DERMAPHARM HOLDING SE (DMP.DE) is 5 / 10 and the dividend payout ratio is 36.59%.